Načítá se...
Liposomal adjuvant development for leishmaniasis vaccines
Leishmaniasis is a parasitic disease that ranges in severity from skin lesions to fatality. Since long-lasting protection is induced upon recovery from cutaneous leishmaniasis, development of an effective vaccine is promising. However, there is no vaccine for use in humans yet. It seems limited effi...
Uloženo v:
| Vydáno v: | Ther Adv Vaccines |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publications
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5697592/ https://ncbi.nlm.nih.gov/pubmed/29201374 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2051013617741578 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|